FCN2 and mesothelioma: FCN2 was positively correlated with most major histocompatibility complexes (MHCs) in LIHC, mesothelioma (MESO), and acute myeloid leukemia (LAML) and negatively correlated with most MHCs in TGCT (Figure 10A).